Welcome to LookChem.com Sign In|Join Free

CAS

  • or

7585-39-9

Post Buying Request

7585-39-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7585-39-9 Usage

Description

Cyclodextrins refer to a family of compounds consisting of sugar molecules bound together in ring (cyclic oligosaccharides). It is produced from starch through enzymatic conversion. Beta-cyclodextrin is the 7-membered sugar ring molecular form of cyclodextrin. Cyclodextrin has various applications. In the pharmaceutical industry, it can be used as complexing agents for increasing the solubility of poorly soluble drug as well as increasing their bioavailability and stability. It can also alleviate the gastrointestinal drug irritation, and prevent drug-drug and drug-excipient interactions. It can also be used in food, pharmaceutical, drug delivery, and chemical industries, as well as agriculture and environmental engineering.

References

https://en.wikipedia.org/wiki/Cyclodextrin https://notendur.hi.is/thorstlo/general.pdf

Chemical Properties

Different sources of media describe the Chemical Properties of 7585-39-9 differently. You can refer to the following data:
1. white powder
2. A biennial herbaceous plant very common in Europe, Asia, Africa and the United States, it has a tapering fleshy root, furrowed stem, finely cut feathery leaves, umbels of small flower heads in midsummer, and capsules containing two curved narrow seeds. The plant grows to about 60 cm and it blooms from May to July. The part used is the fruit, containing approximately 15% of fixed oils and 3 to 7% of essential oil. Caraway has a warm, biting flavor with a strong, fatty, harsh undernote.
3. beta Cyclodextrin is a virtually odorless, slightly sweet-tasting, white or almost white crystalline solid or fine powder.

Occurrence

A derivative of naturally occurring starch.

Uses

Different sources of media describe the Uses of 7585-39-9 differently. You can refer to the following data:
1. Use to solubilize non-polar compounds such as fatty acids, lipids and cholesterol. Reported useful for the selective precipitation of enantiomeric, positional or structural isomersβ-Cyclodextrin is used with dansyl chloride to form water-soluble complexes for fluorescent labeling of proteins. It is an active ingredient of household odor eliminator. It is also used in personal care products like toothpastes, skin creams and dusting powders. It finds applications in the cosmetic industry for products like detergents and perfumes for the controlled release of fragrances. Further, it is used to produce HPLC columns allowing chiral enantiomers separation. In addition to this, it is used to decrease the level of cholesterol in milk fat.
2. β-Cyclodextrin is a cyclic oligosaccharide produced from starch via enzymatic conversion. β-Cyclodextrin is commonly used to produce HPLC columns allowing chiral enantiomers separation.

Preparation

Usually produced commercially from Bacillus macerans or B. circulans fermentation of starch or starch hydrolysate.

Essential oil composition

In addition to carvone, the oil contains d-limonene, carveol, diacetyl furfural, methyl alcohol, acetic aldehyde and other substances. Caraway oil consists of 3.5 to 7% volatile and fatty oils; resin, sugar, tannin, mucilage.

Taste threshold values

Reported to have a taste threshold value lower than that of sucrose with a detection level of 3.9 to 27 ppm and a recognition level of 11 to 52 ppm

General Description

Beta-Cyclodextrin is the most abundant and cheap cyclic oligosaccharide that forms inclusion complexes with several drug molecules. Its main application is in tablet and capsule formulations.Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.

Flammability and Explosibility

Nonflammable

Pharmaceutical Applications

Cyclodextrins are ‘bucketlike’ or ‘conelike’ toroid molecules, with a rigid structure and a central cavity, the size of which varies according to the cyclodextrin type. The internal surface of the cavity is hydrophobic and the outside of the torus is hydrophilic; this is due to the arrangement of hydroxyl groups within the molecule. This arrangement permits the cyclodextrin to accommodate a guest molecule within the cavity, forming an inclusion complex.Cyclodextrins may be used to form inclusion complexes with a variety of drug molecules, resulting primarily in improvements to dissolution and bioavailability owing to enhanced solubility and improved chemical and physical stability.Cyclodextrin inclusion complexes have also been used to mask the unpleasant taste of active materials and to convert a liquid substance into a solid material. b-Cyclodextrin is the most commonly used cyclodextrin, although it is the least soluble. It is the least expensive cyclodextrin; is commercially available from a number of sources; and is able to form inclusion complexes with a number of molecules of pharmaceutical interest. However, b-cyclodextrin is nephrotoxic and should not be used in parenteral formulations. b-Cyclodextrin is primarily used in tablet and capsule formulations. In oral tablet formulations, b-cyclodextrin may be used in both wet-granulation and direct-compression processes. The physical properties of b-cyclodextrin vary depending on the manufacturer. However, b-cyclodextrin tends to possess poor flow properties and requiresalubricant,such as 0.1% w/w magnesium stearate,when it is directly compressed.In parenteral formulations, cyclodextrins have been used to produce stable and soluble preparations of drugs that would otherwise have been formulated using a nonaqueous solvent. In eye drop formulations, cyclodextrins form water-soluble complexes with lipophilic drugs such as corticosteroids. They have been shown to increase the water solubility of the drug; to enhance drug absorption into the eye; to improve aqueous stability; and to reduce local irritation.Cyclodextrins have also been used in the formulation of solutions,suppositories, and cosmetics.

Biochem/physiol Actions

β-Cyclodextrin is the cyclic α heptamer of glucose. It acts as a host to form inclusion compounds with the guests including derivatives of benzene, cyclohexane, adamantane, other alicyclic guests, and also inorganic molecules or ions. It is generally used to solubilize non-polar compounds such a fatty acids, lipids and cholesterol.

Safety

Cyclodextrins are starch derivatives and are mainly used in oral and parenteral pharmaceutical formulations. They are also used in topical and ophthalmic formulations. Cyclodextrins are also used in cosmetics and food products, and are generally regarded as essentially nontoxic and nonirritant materials. However, when administered parenterally, β-cyclodextrin is not metabolized but accumulates in the kidneys as insoluble cholesterol complexes, resulting in severe nephrotoxicity. Cyclodextrin administered orally is metabolized by microflora in the colon, forming the metabolites maltodextrin, maltose, and glucose; these are themselves further metabolized before being finally excreted as carbon dioxide and water. Although a study published in 1957 suggested that orally administered cyclodextrins were highly toxic, more recent animal toxicity studies in rats and dogs have shown this not to be the case, and cyclodextrins are now approved for use in food products and orally administered pharmaceuticals in a number of countries. Cyclodextrins are not irritant to the skin and eyes, or upon inhalation. There is also no evidence to suggest that cyclodextrins are mutagenic or teratogenic. β-Cyclodextrin LD50 (mouse, IP): 0.33 g/kg(16) LD50 (mouse, SC): 0.41 g/kg LD50 (rat, IP): 0.36 g/kg LD50 (rat, IV): 1.0 g/kg LD50 (rat, oral): 18.8 g/kg LD50 (rat, SC): 3.7 g/kg

Check Digit Verification of cas no

The CAS Registry Mumber 7585-39-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,5,8 and 5 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 7585-39:
(6*7)+(5*5)+(4*8)+(3*5)+(2*3)+(1*9)=129
129 % 10 = 9
So 7585-39-9 is a valid CAS Registry Number.
InChI:InChI=1/C42H70O35.H2O/c43-1-8-29-15(50)22(57)36(64-8)72-30-9(2-44)66-38(24(59)17(30)52)74-32-11(4-46)68-40(26(61)19(32)54)76-34-13(6-48)70-42(28(63)21(34)56)77-35-14(7-49)69-41(27(62)20(35)55)75-33-12(5-47)67-39(25(60)18(33)53)73-31-10(3-45)65-37(71-29)23(58)16(31)51;/h8-63H,1-7H2;1H2

7585-39-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (C0777)  β-Cyclodextrin  >99.0%(HPLC)

  • 7585-39-9

  • 25g

  • 565.00CNY

  • Detail
  • TCI America

  • (C0777)  β-Cyclodextrin  >99.0%(HPLC)

  • 7585-39-9

  • 100g

  • 2,290.00CNY

  • Detail
  • USP

  • (1154569)  BetaCyclodextrin  United States Pharmacopeia (USP) Reference Standard

  • 7585-39-9

  • 1707908-30MG

  • 25,262.64CNY

  • Detail
  • USP

  • (1154569)  BetaCyclodextrin  United States Pharmacopeia (USP) Reference Standard

  • 7585-39-9

  • 1154569-250MG

  • 4,662.45CNY

  • Detail
  • Sigma-Aldrich

  • (PHR1439)  Beta-Cyclodextrin  pharmaceutical secondary standard; traceable to USP

  • 7585-39-9

  • PHR1439-1G

  • 791.15CNY

  • Detail
  • Sigma

  • (C4767)  β-Cyclodextrin  ≥97%

  • 7585-39-9

  • C4767-25G

  • 635.31CNY

  • Detail
  • Sigma

  • (C4767)  β-Cyclodextrin  ≥97%

  • 7585-39-9

  • C4767-100G

  • 1,962.09CNY

  • Detail
  • Sigma

  • (C4767)  β-Cyclodextrin  ≥97%

  • 7585-39-9

  • C4767-500G

  • 6,148.35CNY

  • Detail
  • Sigma-Aldrich

  • (B0950000)  Betadex  European Pharmacopoeia (EP) Reference Standard

  • 7585-39-9

  • B0950000

  • 1,880.19CNY

  • Detail

7585-39-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name β-cyclodextrin

1.2 Other means of identification

Product number -
Other names FEMA 4028

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only. Uncategorized
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7585-39-9 SDS

7585-39-9Synthetic route

6A,6B,6D,6E-tetradeoxy-2A,2B,2C,2D,2E,2F,2G,3A,3B,3C,3D,3E,3F,3G,6C,6F,6G-heptadeca-O-benzyl-β-cyclodextrin

6A,6B,6D,6E-tetradeoxy-2A,2B,2C,2D,2E,2F,2G,3A,3B,3C,3D,3E,3F,3G,6C,6F,6G-heptadeca-O-benzyl-β-cyclodextrin

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With palladium 10% on activated carbon; hydrogen In tetrahydrofuran; water regioselective reaction;100%
mono-6-deoxy-6-(p-tolylsulphonyl)-β-cyclodextrin
67217-55-4

mono-6-deoxy-6-(p-tolylsulphonyl)-β-cyclodextrin

A

Mono-3A,6A-anhydrocyclomaltoheptaose
104867-20-1

Mono-3A,6A-anhydrocyclomaltoheptaose

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With sodium hydroxide In water at 40℃; for 11h;A 87.9%
B 8.2%
mono-6-deoxy-6-formyl-β-cyclodextrin
159496-21-6

mono-6-deoxy-6-formyl-β-cyclodextrin

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With sodium tetrahydroborate In water for 24h; Ambient temperature;72%
With sodium tetrahydroborate In methanol; water for 1h;
mono-6-deoxy-6-(p-tolylsulphonyl)-β-cyclodextrin
67217-55-4

mono-6-deoxy-6-(p-tolylsulphonyl)-β-cyclodextrin

A

6(I)-amino-6(I)-deoxycyclomaltoheptaose
29390-67-8

6(I)-amino-6(I)-deoxycyclomaltoheptaose

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With ammonia In water at 60℃; for 5h; Product distribution / selectivity;A 70%
B 30%
C42H70O35*C37H47N3(2+)*2Br(1-)
141484-64-2

C42H70O35*C37H47N3(2+)*2Br(1-)

A

C37H47N3(2+)*2Br(1-)
141484-62-0

C37H47N3(2+)*2Br(1-)

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
In water-d2 at 30℃; Equilibrium constant; Thermodynamic data; other temperatures; free energy of activation at 70 deg C;
C42H70O35*C6H13N3OS

C42H70O35*C6H13N3OS

A

3-t-butyl-1-methyl-1-nitrosothiourea
95598-14-4

3-t-butyl-1-methyl-1-nitrosothiourea

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With acetate buffer at 37℃; Rate constant; dissociation constant and catalyzed rate constant of the inclusion complex is determined;
C42H70O35*C12H14N2
114987-36-9

C42H70O35*C12H14N2

A

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

B

1,1'-dimethyl-1,1'-dihydro-4,4'-bipyridyl
25128-26-1

1,1'-dimethyl-1,1'-dihydro-4,4'-bipyridyl

Conditions
ConditionsYield
In water at 25℃; Equilibrium constant;
prostacyclin*β-cyclodextrin
77164-53-5

prostacyclin*β-cyclodextrin

A

7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-((E)-(S)-3-hydroxy-oct-1-enyl)-cyclopentyl]-6-oxo-heptanoic acid
58962-34-8

7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-((E)-(S)-3-hydroxy-oct-1-enyl)-cyclopentyl]-6-oxo-heptanoic acid

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With phosphate buffer (pH=ca. 7); water at 10 - 30℃; Thermodynamic data; Kinetics; activation parameters: ΔS(excit.), ΔG(excit.), E investigated;
C42H70O35*C21H34O5
69377-76-0

C42H70O35*C21H34O5

A

6-keto-PGF1α methyl ester
63557-55-1

6-keto-PGF1α methyl ester

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With phosphate buffer (pH=ca. 7); water at 10 - 30℃; Thermodynamic data; Kinetics; activation parameters: ΔS(excit.), ΔG(excit.), E investigated;
C42H70O35*C15H17BrNO(1+)*Br(1-)
80800-15-3

C42H70O35*C15H17BrNO(1+)*Br(1-)

A

trimethylammonium bromide
80214-62-6

trimethylammonium bromide

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With Co(NH3)6 at 25℃; Rate constant; Equilibrium constant; host-guest complexation of cyclodextrins with detergents, photoluminescence study;
C42H70O35*C19H25BrNO(1+)*Br(1-)
80800-16-4

C42H70O35*C19H25BrNO(1+)*Br(1-)

A

trimethylammonium bromide
79671-16-2

trimethylammonium bromide

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With Co(NH3)6 at 25℃; Rate constant; Equilibrium constant; host-guest complexation of cyclodextrins with detergents, photoluminescence study;
C42H70O35*C24H35BrNO(1+)*Br(1-)
80822-21-5

C42H70O35*C24H35BrNO(1+)*Br(1-)

A

trimethylammonium bromide
79671-17-3

trimethylammonium bromide

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
With Co(NH3)6 at 25℃; Rate constant; Equilibrium constant; host-guest complexation of cyclodextrins with detergents, photoluminescence study;
C42H70O35*C6H15NO3

C42H70O35*C6H15NO3

A

triethanolamine
102-71-6

triethanolamine

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
In water at 25℃; Equilibrium constant; further temperatures;
C42H70O35*C20H15O2(1-)*Na(1+)

C42H70O35*C20H15O2(1-)*Na(1+)

A

sodium 4-pyren-1-ylbutyrate
63442-80-8

sodium 4-pyren-1-ylbutyrate

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
In water at 25℃; Equilibrium constant; Thermodynamic data; quenching by triethanolamine, ΔH(excit), ΔS(excit), further temperatures;
2C42H70O35*C20H15O2(1-)*Na(1+)

2C42H70O35*C20H15O2(1-)*Na(1+)

A

C42H70O35*C20H15O2(1-)*Na(1+)

C42H70O35*C20H15O2(1-)*Na(1+)

B

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

Conditions
ConditionsYield
In water at 25℃; Equilibrium constant; Thermodynamic data; quenching by triethanolamine, ΔH(excit), ΔS(excit), further temperatures;
β‐cyclodextrin
7585-39-9

β‐cyclodextrin

heptakis(6-bromo-6-deoxy)-β-cyclodextrin
53784-83-1

heptakis(6-bromo-6-deoxy)-β-cyclodextrin

Conditions
ConditionsYield
With bromine; triphenylphosphine In N,N-dimethyl-formamide at 0 - 80℃; for 15h;100%
With tetraethylammonium bromide; 4-pyrrolidin-1-ylpyridine; ethanaminium,N-(difluoro-λ4-sulfanylidene)-N-ethyl-,tetrafluoroborate In N,N-dimethyl-formamide at 20℃; regioselective reaction;97%
With bromine; triphenylphosphine In N,N-dimethyl-formamide at 75 - 80℃;95%
allyl bromide
106-95-6

allyl bromide

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

heptakis(2,3,6-tri-O-allyl)-β-cyclodextrin
141126-40-1

heptakis(2,3,6-tri-O-allyl)-β-cyclodextrin

Conditions
ConditionsYield
Stage #1: β‐cyclodextrin With sodium hydride In N,N-dimethyl-formamide at 60℃; for 2.5h;
Stage #2: allyl bromide In N,N-dimethyl-formamide at 60℃; for 16h; Further stages.;
100%
Stage #1: β‐cyclodextrin With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0 - 5℃; for 1h;
Stage #2: allyl bromide In N,N-dimethyl-formamide; mineral oil at 0 - 20℃;
98%
Stage #1: β‐cyclodextrin With sodium hydride In N,N-dimethyl-formamide; mineral oil at 20℃; for 0.5h; Inert atmosphere;
Stage #2: allyl bromide In N,N-dimethyl-formamide; mineral oil at 20℃; Inert atmosphere;
88%
With sodium hydride In N,N-dimethyl-formamide at 20 - 23℃; for 13h;49%
β‐cyclodextrin
7585-39-9

β‐cyclodextrin

β-CD-fenchene

β-CD-fenchene

Conditions
ConditionsYield
Stage #1: fenchene; β‐cyclodextrin In 1,4-dioxane; water at 20℃; for 0.25h;
Stage #2: In water at 20 - 75℃;
100%
C23H28B10N4OPt(2+)*2NO3(1-)

C23H28B10N4OPt(2+)*2NO3(1-)

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
C23H28B10N4OPt(2+)*2NO3(1-)

C23H28B10N4OPt(2+)*2NO3(1-)

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
C23H28B10N4OPt(2+)*2NO3(1-)

C23H28B10N4OPt(2+)*2NO3(1-)

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
C23H28B10N4OPt(2+)*2NO3(1-)

C23H28B10N4OPt(2+)*2NO3(1-)

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
C23H28B10N4OPt(2+)*2NO3(1-)

C23H28B10N4OPt(2+)*2NO3(1-)

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
C23H28B10N4OPt(2+)*2NO3(1-)

C23H28B10N4OPt(2+)*2NO3(1-)

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
C23H28B10N4OPt(2+)*2NO3(1-)

C23H28B10N4OPt(2+)*2NO3(1-)

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

C23H28B10N4OPt(2+)*2NO3(1-)*C42H70O35

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
[Pt((S)-(1,7-closo-carboran-1-yl)pyrid-3-ylmethanol)2(1,10-phenanthroline)](NO3)2

[Pt((S)-(1,7-closo-carboran-1-yl)pyrid-3-ylmethanol)2(1,10-phenanthroline)](NO3)2

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

[Pt((S)-(1,7-closo-carboran-1-yl)pyrid-3-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

[Pt((S)-(1,7-closo-carboran-1-yl)pyrid-3-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
[Pt((S)-(1,12-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)](NO3)2

[Pt((S)-(1,12-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)](NO3)2

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

[Pt((S)-(1,12-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

[Pt((S)-(1,12-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
[Pt((R)-(1,7-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)](NO3)2

[Pt((R)-(1,7-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)](NO3)2

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

[Pt((R)-(1,7-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

[Pt((R)-(1,7-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
[Pt((S)-(1,7-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)](NO3)2

[Pt((S)-(1,7-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)](NO3)2

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

[Pt((S)-(1,7-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

[Pt((S)-(1,7-closo-carboran-1-yl)pyrid-4-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
[Pt((R)-(1,7-closo-carboran-1-yl)pyrid-3-ylmethanol)2(1,10-phenanthroline)](NO3)2

[Pt((R)-(1,7-closo-carboran-1-yl)pyrid-3-ylmethanol)2(1,10-phenanthroline)](NO3)2

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

[Pt((R)-(1,7-closo-carboran-1-yl)pyrid-3-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

[Pt((R)-(1,7-closo-carboran-1-yl)pyrid-3-ylmethanol)2(1,10-phenanthroline)(β-cyclodextrin)2](NO3)2

Conditions
ConditionsYield
In water for 0.5h; Sonication;100%
benzyl chloride
100-44-7

benzyl chloride

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

2,3,6-Tri-O-benzyl-β-cyclomaltoheptaose
129318-82-7, 130322-65-5, 130322-67-7

2,3,6-Tri-O-benzyl-β-cyclomaltoheptaose

Conditions
ConditionsYield
With sodium hydride In dimethyl sulfoxide at 20℃; for 22h; Inert atmosphere; Schlenk technique;99%
With sodium hydride In dimethyl sulfoxide; mineral oil at 20℃; Inert atmosphere;96%
With sodium hydride In dimethyl sulfoxide95%
3,4,5,6-tetrahydro-2H-pyran-2-one
542-28-9

3,4,5,6-tetrahydro-2H-pyran-2-one

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

polymer; monomer(s): β-cyclodextrin; δ-valerolactone

polymer; monomer(s): β-cyclodextrin; δ-valerolactone

Conditions
ConditionsYield
at 100℃; for 48h;98%
acetic anhydride
108-24-7

acetic anhydride

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

per-O-acetylated β-cyclodextrin

per-O-acetylated β-cyclodextrin

Conditions
ConditionsYield
With copper(II) perchlorate hexahydrate In neat (no solvent) at 20℃; for 0.25h; Inert atmosphere;98%
1,1,1,3,3,3-hexamethyl-disilazane
999-97-3

1,1,1,3,3,3-hexamethyl-disilazane

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

heptakis(2,6-di-O-trimethylsilyl)cyclomaltoheptaose

heptakis(2,6-di-O-trimethylsilyl)cyclomaltoheptaose

Conditions
ConditionsYield
With trimethylsilyl trifluoromethanesulfonate In dichloromethane at 20℃; for 0.25h; Inert atmosphere; regioselective reaction;97%
With iodine at 20℃; Neat (no solvent); Air atmosphere;96%
C20H20N2*2ClH

C20H20N2*2ClH

ClH*C17H16N4
1427351-20-9

ClH*C17H16N4

cucurbituril
80262-44-8

cucurbituril

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C54H52N10*C42H70O35*2C36H36N24O12*4ClH

C54H52N10*C42H70O35*2C36H36N24O12*4ClH

Conditions
ConditionsYield
In water at 60℃; for 0.5h; Huisgen Cycloaddition;97%
2CBP·2Cl

2CBP·2Cl

N-(3,5-dimethoxybenzyl)propargylammonium chloride

N-(3,5-dimethoxybenzyl)propargylammonium chloride

cucurbituril
80262-44-8

cucurbituril

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C42H52N10O4*4ClH*C42H70O35*2C36H36N24O12

C42H52N10O4*4ClH*C42H70O35*2C36H36N24O12

Conditions
ConditionsYield
In water at 20℃; for 1h;97%
1-(2-ethoxyethyl)-4-(pentyn-1-yl)-4-benzoyloxypiperidine oxalate

1-(2-ethoxyethyl)-4-(pentyn-1-yl)-4-benzoyloxypiperidine oxalate

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C42H70O35*C21H29NO3*C2H2O4

C42H70O35*C21H29NO3*C2H2O4

Conditions
ConditionsYield
In ethanol; water97%
Conditions
ConditionsYield
In ethanol; water at 25℃;96.3%
4-(cyclopropylethynyl)-1-(2-ethoxyethyl)-4-(propionyloxy)piperidine

4-(cyclopropylethynyl)-1-(2-ethoxyethyl)-4-(propionyloxy)piperidine

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

β-cyclodextrin

β-cyclodextrin

Conditions
ConditionsYield
In ethanol; water at 50 - 55℃;96.3%
tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

heptakis(6-O-tert-butyldimethylsilyl)-β-cyclodextrin
123155-03-3

heptakis(6-O-tert-butyldimethylsilyl)-β-cyclodextrin

Conditions
ConditionsYield
With pyridine at 20℃; for 18.6667h; Inert atmosphere;96%
With pyridine 1) ice bath, 6.5 h; 2) 18 h, rt;95%
With pyridine90%
acetic anhydride
108-24-7

acetic anhydride

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

peracetylated β-cyclodextrin
23739-88-0

peracetylated β-cyclodextrin

Conditions
ConditionsYield
With iodine at 20℃; for 24h; neat (no solvent);96%
With 1,4-diaza-bicyclo[2.2.2]octane at 55℃; for 4.5h; Neat (no solvent);96%
With lithium perchlorate for 50h; Heating;93%

7585-39-9Relevant articles and documents

Synthesis and reactivity of 6-β-cyclodextrin monoaldehyde: An electrophilic cyclodextrin for the derivatization of macromolecules under mild conditions

Huff,Bieniarz

, p. 7511 - 7516 (1994)

-

Effect of the reaction temperature on the transglycosylation reactions catalyzed by the cyclodextrin glucanotransferase from Bacillus macerans for the synthesis of large-ring cyclodextrins

Qi, Qingsheng,She, Xiaoyan,Endo, Tomohiro,Zimmermann, Wolfgang

, p. 799 - 806 (2004)

The synthesis of cyclodextrins with from 6 to more than 50 glucose units by cyclodextrin glucanotransferase (CGTase, EC 2.4.1.19) from Bacillus macerans was investigated. Analysis of the synthesized cyclic α-1,4-glucan products showed that a higher yield of large-ring cyclodextrins were obtained with a reaction temperature of 60°C compared to 40°C. The yield of large-ring cyclodextrins obtained at 60°C represented about 50% of the total glucans employed in the reaction. Analysis of the cyclodextrin-forming cyclization reaction and of the coupling reaction of the CGTase resulting in the degradation of mainly the larger cyclic α-1,4-glucans indicated higher rates of the cyclization reaction at 60°C compared to 40°C while the opposite was found for the coupling reaction.

Photochromism of dithienylethenes included in cyclodextrins

Takeshita, Michinori,Kato, Nobuo,Kawauchi, Susumu,Imase, Tatsuya,Watanabe, Junji,Irie, Masahiro

, p. 9306 - 9313 (1998)

The effect of inclusion of diarylethenes in cyclodextrin cavities on cyclization quantum yields and on circular dichroism (CD) spectral changes by photoirradiation was studied. The addition of β-and γ-cyclodextrins to an aqueous solution of the open-ring form of 2,2'-dimethyl-3,3'-(perfluoro- cyclopentene-1,2-diyl)bis(benzo[b]thiophene-6-sulfonate) (1a) increased the ratio of the antiparallel conformation. The enrichment of antiparallel conformation caused an increase in the photocyclization quantum yield of 1a. The CD spectral intensity of the mixtures of 1a or 2,2'4,4'-tetramethyl- 3,3'-(perfluorocyclopentene-1,2-dyl)bis(thiophen-5-yl-(phenyl-4-sulfonate)) (2a) and cyclodextrins in aqueous solution increased with the increasing concentration of cyclodextrins. The induced CD spectrum of 1 in β- cyclodextrin reversibly changed from negative to positive by UV irradiation. The spectral change was attributed to the change in the direction of transition moment of 1 in the cavity.

Characterization of cyclodextrin glycosyltransferase immobilized on silica microspheres via aminopropyltrimethoxysilane as a spacer arm

Matte, Carla Roberta,Nunes, Michael Ramos,Benvenutti, Edilson Valmir,Schoeffer, Jessie Da Natividade,Ayub, Marco Antonio Zachia,Hertz, Plinho Francisco

, p. 51 - 56 (2012)

In this work, the enzymatic properties of immobilized cyclodextrin glycosyltransferase (CGTase) of Thermoanaerobacter sp. were investigated and compared with the soluble form of the enzyme. CGTase was immobilized on mesoporous silica microspheres synthesized using polyethylene glycol 400 as swelling agent, silanized with 3-aminopropyltrimethoxysilane (APTMS), and activated with glutaraldehyde prior to immobilization. This innovative approach for support preparation produced high yields of immobilization (83%) and activity recoveries (73%), which are the highest so far reported for CGTase. The soluble enzyme (CGTase) and its immobilized form (ImCGTase) showed similar values for the optimal pH activity, while optimal reaction temperatures were found to be 100 °C and 80 °C, respectively. The immobilized enzyme showed similar values for Km and thermal stabilities with the soluble form, while its Vmax was lower. The immobilized enzyme was tested in repeated batches in order to simulate recovery and reuse, keeping about 60% of the initial catalytic activity after 15 cycles, showing its good chemical and mechanical resistance.

Preservation of Bacillus firmus strain 37 and optimization of cyclodextrin biosynthesis by cells immobilized on loofa sponge

Pazzetto, Rubia,De Souza Ferreira, Sabrina Barbosa,Santos, Elder James Silva,Moriwaki, Cristiane,Guedes, Teresinha Aparecida,Matioli, Graciette

, p. 9476 - 9488 (2012)

The preservation of Bacillus firmus strain 37 cells by lyophilization was evaluated and response surface methodology (RSM) was used to optimize the β-cyclodextrin (β-CD) production by cells immobilized on loofa sponge. Interactions were studied with the variables temperature, pH and dextrin concentration using a central composite design (CCD). Immobilization time influence on β-CD production was also investigated. B. firmus strain 37 cells remained viable after one year of storage, showing that the lyophilization is a suitable method for preservation of the microorganism. From the three-dimensional diagrams and contour plots, the best conditions for β-CD production were determined: temperature 60 °C, pH 8, and 18% dextrin. Considering that the amount of dextrin was high, a new assay was carried out, in which dextrin concentrations of 10, 15, and 18% were tested and the temperature of 60 °C and pH 8 were maintained. The results achieved showed very small differences and therefore, for economic reasons, the use of 10% dextrin is suggested. Increasing the immobilization time of cells immobilized on synthetic sponge the β-CD production decreased and did not change for cells immobilized on loofa sponge. The results of this research are important for microorganism preservation and essential in the optimization of the biosynthesis of CD.

Chiral recognition for the complexation dynamics of β-cyclodextrin with the enantiomers of 2-naphthyl-1-ethanol

Tang, Hao,Sutherland, Andria S. M.,Osusky, Lana M.,Li, Yan,Holzwarth, Josef F.,Bohne, Cornelia

, p. 358 - 369 (2014)

The focus of this study is to understand the origin of the chiral recognition for a host-guest system containing complexes with different stoichiometries. Each enantiomer of 2-naphthyl-1-ethanol forms two different 1:1 complexes with β-cyclodextrin, leading to the formation of three different 2:2 complexes. One of these 2:2 complexes leads to excimer emission of the guest. Fluorescence studies were employed to determine the binding isotherms for the 1:1 and 2:2 complexes. No chiral discrimination was directly observed for the formation of the 1:1 complexes, while higher equilibrium constants (29% from binding isotherms and 40% from kinetic studies) were observed for the formation of the 2:2 complexes with (R)-2-naphthyl-1-ethanol when compared to the formation of the 2:2 complexes formed from (S)-2-naphthyl-1-ethanol. The relaxation kinetics was studied using stopped-flow experiments. The formation of the 2:2 complexes was followed by detecting the excimer emission from one of the 2:2 complexes. The relaxation kinetics was faster for (S)-2-naphthyl-1- ethanol, where a higher dissociation rate constant, by 47%, was observed, suggesting that the chiral discrimination occurs because the interaction between two cyclodextrins is more favorable for the complexes containing (R)-2-naphthyl-1-ethanol when compared to (S)-2-naphthyl-1-ethanol. The same overall equilibrium constants were observed for the 1:1 complexes with both enantiomers showing that at a given cyclodextrin concentration the sum of the two types of 1:1 complexes is the same for both enantiomers. However, analysis of the binding isotherms indicates that the ratio between the two different 1:1 complexes for each enantiomer was different for (R)- and (S)-2-naphthyl-1- ethanol. The Royal Society of Chemistry and Owner Societies.

DIBAL-H mediated triple and quadruple debenzylations of perbenzylated cyclodextrins

Rawal, Girish K.,Rani, Shikha,Ward, Sandra,Ling, Chang-Chun

, p. 171 - 180 (2010)

Diisobutylaluminium hydride (DIBAL-H) mediated reductive removal of benzyl groups was investigated for perbenzylated α-, β- and γ-cyclodextrins using DIBAL-H in hexane as the reagent. It was found that under the new conditions, the debenzylation can be better controlled to provide sequentially tri- and tetra-debenzylated products in moderate yields and in a regioselective manner. In the case of α-cyclodextrin, the removal of the third and fourth benzyl groups took a different path involving the secondary rim, compared to β- and γ-cyclodextrins which both gave only 6-O-debenzylated products. The Royal Society of Chemistry 2010.

Enzyme-mediated dynamic combinatorial chemistry allows out-of-equilibrium template-directed synthesis of macrocyclic oligosaccharides

Larsen, Dennis,Beeren, Sophie R.

, p. 9981 - 9987 (2019/11/14)

We show that the outcome of enzymatic reactions can be manipulated and controlled by using artificial template molecules to direct the self-assembly of specific products in an enzyme-mediated dynamic system. Specifically, we utilize a glycosyltransferase to generate a complex dynamic mixture of interconverting linear and macrocyclic α-1,4-d-glucans (cyclodextrins). We find that the native cyclodextrins (α, β and γ) are formed out-of-equilibrium as part of a kinetically trapped subsystem, that surprisingly operates transiently like a Dynamic Combinatorial Library (DCL) under thermodynamic control. By addition of different templates, we can promote the synthesis of each of the native cyclodextrins with 89-99% selectivity, or alternatively, we can amplify the synthesis of unusual large-ring cyclodextrins (δ and ?) with 9 and 10 glucose units per macrocycle. In the absence of templates, the transient DCL lasts less than a day, and cyclodextrins convert rapidly to short maltooligosaccharides. Templates stabilize the kinetically trapped subsystem enabling robust selective synthesis of cyclodextrins, as demonstrated by the high-yielding sequential interconversion of cyclodextrins in a single reaction vessel. Our results show that given the right balance between thermodynamic and kinetic control, templates can direct out-of-equilibrium self-assembly, and be used to manipulate enzymatic transformations to favor specific and/or alternative products to those selected in Nature.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 7585-39-9